Advertisement
Screener

89bio, Inc. Pre-Tax Income

89bio, Inc. Pre-Tax Income

89bio, Inc. reported Pre-Tax Income of -$110.75 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.

Financial Statements › Income Statement

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2025-08-08

  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-06-30 was -$110.75M.
  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-03-31 was -$71.14M.
  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-12-31 was -$118.10M.
  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-09-30 was -$148.87M.
  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$366.39M.
  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$138.32M.
  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$102.01M.
  • 89bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$90.27M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 11 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month
2025-06-30-$110.75M
10-Q · filed 2025-08-08
-$181.89M
10-Q · filed 2025-08-08
-$299.99M
derived: sum of 3 quarters · filed 2025-08-08
-$448.86M
derived: sum of 4 quarters · filed 2025-08-08
2025-03-31-$71.14M
10-Q · filed 2025-05-02
-$189.24M
derived: sum of 2 quarters · filed 2025-05-02
-$338.10M
derived: sum of 3 quarters · filed 2025-05-02
-$385.94M
derived: sum of 4 quarters · filed 2025-08-08
2024-12-31-$118.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$266.97M
derived: sum of 2 quarters · filed 2025-02-27
-$314.80M
derived: sum of 3 quarters · filed 2025-08-08
-$366.39M
10-K · filed 2025-02-27
2024-09-30-$148.87M
10-Q · filed 2024-11-07
-$196.71M
derived: sum of 2 quarters · filed 2025-08-08
-$248.29M
10-Q · filed 2024-11-07
-$284.66M
derived: sum of 4 quarters · filed 2025-08-08
2024-06-30-$47.84M
10-Q · filed 2025-08-08
-$99.42M
10-Q · filed 2025-08-08
-$135.79M
derived: sum of 3 quarters · filed 2025-08-08
-$170.51M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31-$51.58M
10-Q · filed 2025-05-02
-$87.95M
derived: sum of 2 quarters · filed 2025-05-02
-$122.68M
derived: sum of 3 quarters · filed 2025-05-02
-$161.07M
derived: sum of 4 quarters · filed 2025-05-02
2023-12-31-$36.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$71.09M
derived: sum of 2 quarters · filed 2025-02-27
-$109.49M
derived: sum of 3 quarters · filed 2025-02-27
-$138.32M
10-K · filed 2025-02-27
2023-09-30-$34.73M
10-Q · filed 2024-11-07
-$73.12M
derived: sum of 2 quarters · filed 2024-11-07
-$101.95M
10-Q · filed 2024-11-07
-$126.54M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$38.39M
10-Q · filed 2024-08-05
-$67.23M
10-Q · filed 2024-08-05
-$91.81M
derived: sum of 3 quarters · filed 2025-02-27
-$118.62M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$28.84M
10-Q · filed 2024-05-09
-$53.42M
derived: sum of 2 quarters · filed 2025-02-27
-$80.22M
derived: sum of 3 quarters · filed 2025-02-27
-$105.28M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$24.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$51.39M
derived: sum of 2 quarters · filed 2025-02-27
-$76.44M
derived: sum of 3 quarters · filed 2025-02-27
-$102.01M
10-K · filed 2025-02-27
2022-09-30-$26.80M
10-Q · filed 2023-11-09
-$51.86M
derived: sum of 2 quarters · filed 2023-11-09
-$77.42M
10-Q · filed 2023-11-09
-$103.86M
derived: sum of 4 quarters · filed 2024-03-01
2022-06-30-$25.05M
10-Q · filed 2023-08-09
-$50.62M
10-Q · filed 2023-08-09
-$77.05M
derived: sum of 3 quarters · filed 2024-03-01
-$105.38M
derived: sum of 4 quarters · filed 2024-03-01
2022-03-31-$25.56M
10-Q · filed 2023-05-08
-$52.00M
derived: sum of 2 quarters · filed 2024-03-01
-$80.33M
derived: sum of 3 quarters · filed 2024-03-01
-$101.05M
derived: sum of 4 quarters · filed 2024-03-01
2021-12-31-$26.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
-$54.76M
derived: sum of 2 quarters · filed 2024-03-01
-$75.49M
derived: sum of 3 quarters · filed 2024-03-01
-$90.27M
10-K · filed 2024-03-01
2021-09-30-$28.33M
10-Q · filed 2022-11-10
-$49.05M
derived: sum of 2 quarters · filed 2022-11-10
-$63.83M
10-Q · filed 2022-11-10
-$76.50M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$20.72M
10-Q · filed 2022-08-11
-$35.51M
10-Q · filed 2022-08-11
-$48.17M
derived: sum of 3 quarters · filed 2022-08-11
-$62.75M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$14.78M
10-Q · filed 2022-05-12
-$27.45M
derived: sum of 2 quarters · filed 2022-05-12
-$42.02M
derived: sum of 3 quarters · filed 2022-05-12
-$53.80M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$12.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
-$27.24M
derived: sum of 2 quarters · filed 2022-03-24
-$39.01M
derived: sum of 3 quarters · filed 2022-03-24
-$49.56M
10-K · filed 2022-03-24
2020-09-30-$14.58M
10-Q · filed 2021-11-12
-$26.35M
derived: sum of 2 quarters · filed 2021-11-12
-$36.90M
10-Q · filed 2021-11-12
-$56.05M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$11.77M
10-Q · filed 2021-08-13
-$22.32M
10-Q · filed 2021-08-13
-$41.47M
derived: sum of 3 quarters · filed 2021-08-13
-$60.13M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31-$10.54M
10-Q · filed 2021-05-14
-$29.70M
derived: sum of 2 quarters · filed 2021-05-14
-$48.36M
derived: sum of 3 quarters · filed 2021-05-14
-$63.33M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$19.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$37.82M
derived: sum of 2 quarters · filed 2021-03-25
-$52.79M
derived: sum of 3 quarters · filed 2021-03-25
-$57.20M
10-K · filed 2021-03-25
2019-09-30-$18.67M
10-Q · filed 2020-11-13
-$33.63M
derived: sum of 2 quarters · filed 2020-11-13
-$38.05M
10-Q · filed 2020-11-13
2019-06-30-$14.97M
10-Q · filed 2020-08-13
-$19.38M
10-Q · filed 2020-08-13
2019-03-31-$4.42M
10-Q · filed 2020-05-13
2018-12-31-$16.15M
10-K · filed 2020-03-18
2018-09-30-$4.17M
10-Q · filed 2019-12-18
-$11.54M
10-Q · filed 2019-12-18